Multiple myeloma and Injection site extravasation
Summary:
Injection site extravasation is found among people with Multiple myeloma, especially for people who are male, 60+ old.
The study analyzes which people have Injection site extravasation with Multiple myeloma. It is created by eHealthMe based on reports of 21 people who have Multiple myeloma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Multiple myeloma?
Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,107 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.
What is Injection site extravasation?
Injection site extravasation (flow of (blood or lymph) from injection site) is found to be associated with 555 drugs and 730 conditions by eHealthMe. Check the latest studies of Injection site extravasation.
21 people who have Multiple Myeloma and Injection Site Extravasation are studied.

Gender of people who have Multiple Myeloma and experienced Injection Site Extravasation *:
- female: 50 %
- male: 50 %
Age of people who have Multiple Myeloma and experienced Injection Site Extravasation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 13.33 %
- 60+: 86.67 %
Common co-existing conditions for these people *:
- Stress And Anxiety: 1 person, 4.76%
- Pain: 1 person, 4.76%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.76%
- Insomnia (sleeplessness): 1 person, 4.76%
- Incontinence (lack of moderation or self-control): 1 person, 4.76%
- Gastric Disorder (disease of stomach): 1 person, 4.76%
- Cerebral Vasoconstriction (constriction of brain blood vessels): 1 person, 4.76%
Common drugs taken by these people *:
- Darzalex: 10 people, 47.62%
- Kyprolis: 5 people, 23.81%
- Revlimid: 4 people, 19.05%
- Zometa: 2 people, 9.52%
- Aredia: 2 people, 9.52%
- Lenalidomide: 1 person, 4.76%
- Aranesp: 1 person, 4.76%
- Dantrium: 1 person, 4.76%
- Darzalex Faspro: 1 person, 4.76%
- Decadron: 1 person, 4.76%
Common symptoms for these people *:
- Fever: 2 people, 9.52%
- Injection Site Irritation: 2 people, 9.52%
- Injection Site Pain: 2 people, 9.52%
- Swelling: 2 people, 9.52%
- Injection Site Swelling: 2 people, 9.52%
- Gallstones (stone formation by bile component): 1 person, 4.76%
- Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 1 person, 4.76%
- Hypernatraemia (an abnormally high plasma concentration of sodium ions): 1 person, 4.76%
- Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 4.76%
- Wheezing (a high-pitched whistling sound made while you breath): 1 person, 4.76%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Injection site extravasation?
- Check whether Injection site extravasation is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Multiple myeloma (516,725 reports)
- Injection site extravasation (14,458 reports)
All the drugs that are associated with Injection site extravasation:
- Injection site extravasation (555 drugs)
All the conditions that are associated with Injection site extravasation:
- Injection site extravasation (730 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Injection site extravasation and Multiple myeloma, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Benzonatate cause Hepatic Failure? - a second ago
- Could Mycophenolic Acid cause Hepatocellular Carcinoma? - 7 seconds ago
- Cefazolin and Tranexamic Acid drug interactions for women aged 60+ - 17 seconds ago
- Enalapril Maleate and Dyspnoea Exertional for Women aged 60+ - 22 seconds ago
- Enalapril Maleate and Dyspnea Exertional for Women aged 60+ - 22 seconds ago
- Drug interactions of Zelnorm and Clopidogrel - 25 seconds ago
- Could Xarelto cause Orthostatic Hypotension? - 26 seconds ago
- Altace and Pain for Women aged 30-39 - 27 seconds ago
- Altace and Pain Relief for Women aged 30-39 - 27 seconds ago
- Altace and Alternative Medicine - Pain Relief for Women aged 30-39 - 27 seconds ago